false
0001607962
00-0000000
0001607962
2026-09-15
2026-09-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
September 15, 2026
Lifeward Ltd.
(Exact name of registrant as specified in its charter)
| Israel |
|
001-36612 |
|
Not applicable |
|
(State or other jurisdiction of
incorporation or organization) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
| 2 Cabot Rd., Hudson, MA |
|
01749 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: +508.251.1154
Not Applicable
(Former name or former address, if changed since
last report)
| Securities registered pursuant to
Section 12(b) of the Exchange Act
|
|
Trading Symbol |
|
Name of each exchange on which
registered
|
| Ordinary Shares, no par value |
|
LFWD |
|
Nasdaq Capital Market |
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.08 Shareholder Director Nominations.
The Board of Directors (the “Board”)
of Lifeward Ltd. (the “Company”) has set October 30, 2026 as the date for the Company’s 2026 Annual and Extraordinary
General Meeting of Shareholders (the “Annual Meeting”). Because the Annual Meeting will be held more than 30 days from the
anniversary date of the Company’s 2025 annual general meeting of shareholders, shareholders of the Company who wish to have a proposal
considered for inclusion in the Company’s proxy materials for the Annual Meeting pursuant to Rule 14a-8 of the Securities Exchange
Act of 1934, as amended, must ensure that such proposal is received by the Company’s Interim Chief Executive Officer at the Company’s
office located at Lifeward Ltd., 3 Hatnufa Street, 6th Floor, Yokneam Ilit, Israel, on or before September 23, 2026, including any notice
on Schedule 14N, which the Company has determined is a reasonable time before it expects to begin to print and send its proxy materials.
All shareholder proposals and nominations must comply with the rules and regulations promulgated by the Securities and Exchange Commission,
the Israel Companies Law 5759-1999, and the Company’s Articles of Association, as applicable.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
Lifeward Ltd. |
| Dated: September 15, 2026 |
By: |
/s/ Almog Adar |
| |
Name: |
Almog Adar |
| |
Title: |
Chief Financial Officer |
